Annals of Emergency Medicine
Volume 30, Issue 1 , Pages 40-44 , July 1997

Thrombocytopenia Following Timber Rattlesnake Envenomation

Received 7 April 1997 ,Accepted 24 April 1997.

References 

  1. Glenn JL, Straight RC, Wolfe MC, et al.  Geographical variation in Crotalus scutulatus scutulatus (Mojave rattlesnake) venom properties. Toxicon. 1983;21:119–130
  2. Glenn JL, Straight C, Wolt TB. Regional variation in the presence of canebrake toxin in Crotalus horridus venom. Comp Biochem Physiol C Pharmacol Toxicol Endocrinol. 1994;107:337–346
  3. Straight RC, Glenn JL, Wolt TB, et al.  Regional differences in content of small basic peptide toxins in the venoms of Crotalus adamanteus and Crotalus horridus. Comp Biochem Physiol C Pharmacol Toxicol Endocrinol. 1991;100:51–58
  4. Smith MS, Ownby CL. Ability of polyvalent (Crotalidae) antivenin to neutralize myonecrosis, hemorrhage and lethality induced by timber rattlesnake (Crotalus horridus horridus) venom. Toxicon. 1985;23:409–424
  5. Jansen PW, Perkin RM, Van Stralen D. Mojave rattlesnake envenomation: Prolonged neurotoxicity and rhabdomyolysis. Ann Emerg Med. 1992;21:322–325
  6. Furlow TG, Brennan LV. Purpura following timber rattlesnake (Crotalus horridus horridus) envenomation. Cutis. 1985;234–236
  7. Hasiba C, Rosenbach LM, Rockwell D, et al.  DIC-like syndrome after envenomation by the snake, Crotalus. N Engl J Med. 1975;292:505–507
  8. Tallon RW, Koch KL, Barnes SG, et al.  Correspondence. N Engl J Med. 1981;305:1347–1348
  9. Schmaier AH, Claypool W, Colman RW. Crotalocytin: Recognition and purification of a timber rattlesnake platelet activating protein. Blood. 1980;56:1013–1019
  10. Burgess JL, Dart RC. Snake venom coagulopathy and abuse of blood products in the treatment of pit viper envenomation. Ann Emerg Med. 1991;20:795–801
  11. Shiels AL. Snakes in Pennsylvania. Harrisburg, PA: Pennsylvania Fish and Boat Commission; 1996;
  12. Linzey DW, Clifford MJ. Snakes of Virginia. Charlottesville, VA: University Press of Virginia; 1981;
  13. Mitchell JC. The snakes of Virginia. Virginia Wildlife. 1974;35:16–18
  14. Wingert WA, Chan L. Rattlesnake bites in southern California and rationale for recommended treatment. West J Med. 1988;148:37–44
  15. Pirkle H, Stocker K. Thrombin like enzymes from snake venoms: An inventory. Thromb Haemost. 1991;65:440–450
  16. Bonilla CA. Defibrinating enzyme from timber rattlesnake (Crotalus horridus horridus) venom: A potential agent for therapeutic defibrination. Thromb Res. 1975;6:151–169
  17. Riffer E, Curry SC, Gerkin R. Successful treatment with antivenin of marked thrombocytopenia without significant coagulopathy following rattlesnake bites. Ann Emerg Med. 1987;16:1297–1299
  18. Schmaier AH, Colman RW. Crotalocytin: Characterization of the timber rattlesnake platelet activating protein. Blood. 1980;56:1020–1028
  19. Longenecker GL. Effects of snake venoms on blood platelets. In:  Tu AT editors. Reptile Venoms and Toxins. 5:New York: Marcel Dekker; 1991;p. 189–224

 From the Departments of Emergency Medicine and Pediatrics, University of Virginia, Charlottesville, VA;* and the Central Pennsylvania Poison Center and the Center for Emergency Medical Services,§ Milton S Hershey Medical Center, Pennsylvania State University, Hershey, PA.

☆☆ Reprint no. 47/1/82828

 Reprints not available from the authors.

PII: S0196-0644(97)70108-2

Annals of Emergency Medicine
Volume 30, Issue 1 , Pages 40-44 , July 1997